| Revenue growth | 9% YoY for FY26; 6% YoY for Q4 FY26. |
|---|---|
| Margins | FY26 EBITDA margin improved to 15.8% from 13.0% YoY. |
| Demand visibility | Strong domestic momentum; reaching 1.2 crore households in India. |
| Management confidence | High; citing market leadership across general and modern trade channels. |
Growth
FY26 revenue grew 9% YoY; PAT grew 36% to ₹648 cr. Q4 domestic revenue surged 22%.
Outlook
Focus on 'democratizing distribution' with 3.4 lakh outlets and expansion into Masala Meal Mixes.
Risks
Q4 exports were partially impacted by lower volumes to the Middle East region.
Earnings Call filed with BSE, NSE: KRBL. Summary written with AI assistance from the document.
KRBL Ltd: key numbers
- Share price
- ₹392.65
- Market cap
- ₹8,987 Cr
- Revenue (annual)
- ₹6,098 Cr
- Net profit (annual)
- ₹648.0 Cr
- P/E (TTM)
- 11.8×Sector 28.6×
- Promoter holding
- 60.17%+0.00% QoQ
- FII holding
- 7.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KRBL Ltd
All →KRBL Annual General Meeting
KRBL Limited held its 33rd Annual General Meeting on September 24, 2026. Shareholders considered financial statements, dividends, director re-appointment, and cost auditor remuneration.
KRBL Other Announcement
KRBL Limited has informed shareholders about the web link to access the 33rd AGM notice and Annual Report for FY 2025-26, fulfilling regulatory requirements.
KRBL Annual Report
KRBL Limited has filed its Annual Report for the financial year ended March 31, 2026. The report includes the Business Responsibility and Sustainability Report.
KRBL Annual General Meeting
KRBL Limited will hold its 33rd Annual General Meeting on September 24, 2026, through video conferencing. The meeting agenda includes the declaration of a final dividend.
KRBL Business Update
KRBL Limited CFO Ashish Jain participated in a media interaction with NDTV Profit News. The company shared a link to the recorded interview for investors.
KRBL Credit Rating
KRBL Limited announced the withdrawal of credit ratings for its commercial papers by CARE Ratings, as no amounts remain outstanding against the instrument.